These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intraportal islet allografts in type I diabetes mellitus. Alejandro R; Burke G; Shapiro ET; Strasser S; Nery J; Ricordi C; Esquenazi V; Miller J; Mintz DH Transplant Proc; 1992 Jun; 24(3):959-60. PubMed ID: 1604685 [No Abstract] [Full Text] [Related]
4. Islet allotransplantation in type I diabetic patients: effects of islet cell number on clinical outcome. Secchi A; Socci C; Maffi P; Falqui L; Bertuzzi F; De Nittis P; Piemonti L; Taglietti MV; Di Carlo V; Pozza G Transplant Proc; 1996 Oct; 28(5):2861-5. PubMed ID: 8908102 [No Abstract] [Full Text] [Related]
5. Comparison of transplanted islets in patients with functioning versus nonfunctioning allografts. Swanson CJ; Olack BJ; Flavin KS; Mohanakumar T; Brennan DC; White NH; Lacy PE; Scharp DW Transplant Proc; 1997 Jun; 29(4):2241-2. PubMed ID: 9193609 [No Abstract] [Full Text] [Related]
6. Allotransplantation of fresh and cryopreserved islets in patients with type I diabetes: two-year experience. Socci C; Davalli AM; Maffi P; Falqui L; Secchi A; Bertuzzi F; Vignali A; Magistretti P; Zammarchi O; Scaglia L Transplant Proc; 1993 Feb; 25(1 Pt 2):989-91. PubMed ID: 8442294 [No Abstract] [Full Text] [Related]
7. Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin. Gores PF; Najarian JS; Stephanian E; Lloveras JJ; Kelley SL; Sutherland DE Lancet; 1993 Jan; 341(8836):19-21. PubMed ID: 8093268 [TBL] [Abstract][Full Text] [Related]
8. Transplantation of unpurified islets from single donors with 15-deoxyspergualin. Gores PF; Najarian JS; Stephanian E; Lloveras JJ; Kelley SL; Sutherland DE Transplant Proc; 1994 Apr; 26(2):574-5. PubMed ID: 8171561 [No Abstract] [Full Text] [Related]
9. Deoxyspergualin--a different and intriguing immunosuppressant. Tufveson G; Gannedahl G Transplant Proc; 1994 Oct; 26(5):3029-39. PubMed ID: 7940954 [No Abstract] [Full Text] [Related]
10. Advantages of microencapsulation as an immunoprotection method in the transplantation of pancreatic islets. Sun AM Ann Transplant; 1997; 2(3):55-62. PubMed ID: 9869865 [No Abstract] [Full Text] [Related]
11. Is immunosuppression justified for nonuremic diabetic patients to keep them insulin independent? (The argument for). Sutherland DE Transplant Proc; 2002 Aug; 34(5):1927-8. PubMed ID: 12176632 [No Abstract] [Full Text] [Related]
12. New strategies for clinical islet transplantation. The role of purified grafts and immunosuppressive therapy. Gores PF; Kaufman DB; Sutherland DE Ann N Y Acad Sci; 1993 Nov; 696():377-89. PubMed ID: 8109844 [No Abstract] [Full Text] [Related]